XML 70 R53.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS' EQUITY - Stock grant agreements with non-employees (Details) - SADA License Agreement - Researchers, Employees of MSK
1 Months Ended 6 Months Ended 27 Months Ended
Jul. 31, 2020
USD ($)
individual
Apr. 30, 2020
USD ($)
individual
shares
Jun. 30, 2022
USD ($)
individual
Jun. 30, 2022
USD ($)
Share-Based Compensation Awards        
Number of individuals | individual 2      
Notes receivable, noncurrent $ 2,610,000      
Notes receivable term 3 years      
Notes receivable interest rate (as a percent) 1.00%      
Nonemployees        
Share-Based Compensation Awards        
Number of individuals | individual   2 2  
Vesting (as a percent)   40.00% 20.00% 80.00%
Remaining vesting percentage   60.00% 20.00% 20.00%
Nonemployees | Research and development expense        
Share-Based Compensation Awards        
Non-cash expense in connection with equity issuance to non-employees   $ 7,376,000    
Unrecognized compensation     $ 0 $ 0
Nonemployees | Tranche two        
Share-Based Compensation Awards        
Vesting period   3 years    
Common Stock | Nonemployees        
Share-Based Compensation Awards        
Shares agreed to be issued | shares   213,996    
Issuance of common stock to non-employees (in shares) | shares   213,996